聯影醫療(688271.SH):目前在全球範圍內有四個主要生產基地
格隆匯5月16日丨聯影醫療(688271.SH)於2023年4月29日、5月7日參加分析師會議、電話會議或者召開業績説明會,公司表示,目前公司在全球範圍內有四個主要生產基地,分別位於上海、常州、武漢和美國休斯頓。
截至目前,公司的上海生產基地、武漢生產基地、常州生產基地以及美國生產基地均已獲得ISO 13485醫療器械管理體系認證,生產基地認證覆蓋率達100%;公司的上海生產基地、武漢生產基地亦獲得ISO 9001質量管理體系認證;公司多款產品已獲得美國Nationally Recognized Testing Laboratory (NRTL)認證。
公司的募投項目之一高端醫療影像設備產業化基金項目的建設內容包括智能製造工廠的建設、生產研發樓和配套綜合樓以及其他配套設施的建設。2022年,公司產業化示範基地二期項目已正式開工,規劃建築面積約42萬平方米,將建設成為集技術研發、智能製造、國際交流培訓、全球品牌展示、生活服務、中央公園等功能於一體的智慧園區。公司的新基地還將打造數智化超級工廠,藉助工業物聯網、大數據、人工智能等前沿技術,實現生產製造、倉儲、物流等各環節要素全面感知和控制,以精益化、自動化、智能化的生產及運營管理,大幅提升全線高端產品全球供給能力與速度,進一步提升公司智能生產水平,豐富高端產品線系列,為公司的全球化戰略佈局作出有力的支撐。
未來,公司以市場需求為導向,積極進行各主要基地的產能優化和升級,以契合度更好、響應度更快的要求對各生產基地的轉場和產線切入進行精細化的調整和系統性驗證,進一步強化上述各基地的產能建設能力和佈局,以滿足對各級臨牀用户需求,保證公司的可持續穩定生產能力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.